title: Duration of delayed graft function is an important predictor of 1-year serum creatinine.
abstract: OBJECTIVE
  The purpose of this study was to evaluate the importance of various factors on 1-year serum creatinine (SCr) as a surrogate endpoint for allograft survival among a series of kidney transplantations performed at 2 centers.
  
  
  METHODS
  Two hundred sixty consecutive renal transplantations were included with overall mean age of 40 +/- 13 years, including 55% men and 19% living donor grafts. Factors considered for analysis were donor and recipient ages, and sexes, number of transplantations, panel-reactive antibodies, total number of HLA mismatches, cold ischemia time (CIT), acute rejection (AR) rate, and presence/duration of delayed graft function (DGF). Multiple regression analyses were performed for 1-year SCr, AR rate, and DGF duration.
  
  
  RESULTS
  One-year SCr was 1.46 +/- 0.5 mg/dL, 6-month AR rate was 22%, and DGF rate was 29% of mean duration 3 +/- 8 days. Multiple regression analysis for lower 1-year SCr value identified as significant female recipient sex, lower donor age, absence of AR within 6 months, and decreased DGF duration (P < .05). The only significant factor affecting AR rate was DGF duration. Finally, prolonged CIT was associated with a longer DGF duration.
  
  
  CONCLUSIONS
  We confirmed that 1-year SCr was primarily affected by well-known factors, such as AR incidence, donor age, and female recipient sex. However, we identified DGF duration as a significant factor affecting 1-year SCr. AR rate was also associated with DGF duration, which in turn depended upon longer CIT.
authors.affiliation: Universidad Catolica de Chile, Departmento de Urologia, Santiago, Chile. javierdomi@hotmail.com
authors.forename: J
authors.initials: J
authors.lastname: Domínguez
authors.forename: F
authors.initials: F
authors.lastname: Lira
authors.forename: R
authors.initials: R
authors.lastname: Rebolledo
authors.forename: P
authors.initials: P
authors.lastname: Troncoso
authors.forename: C
authors.initials: C
authors.lastname: Aravena
authors.forename: M
authors.initials: M
authors.lastname: Ortiz
authors.forename: R
authors.initials: R
authors.lastname: Gonzalez
mesh_terms: D000328:Adult; D002102:Cadaver; D003404:Creatinine / Q000097:blood*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology; D006085:Graft Survival / Q000502:physiology*; D006680:HLA Antigens / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D007518:Isoantibodies / Q000276:immunology; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D013997:Time Factors; D014019:Tissue Donors
chemical_list: D006680:HLA Antigens; D007518:Isoantibodies; D003404:Creatinine